Similar articles

• Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?

  Baskin S, Neher JO, Dodson S, Hoffman R. Baskin S, et al. J Fam Pract. 2005 Aug;54(8):723-4. J Fam Pract. 2005. PMID: 16061064 Review. No abstract available.
• Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.

  Patel RR. Patel RR. Cardiol Rev. 2009 May-Jun;17(3):132-5. doi: 10.1097/CRD.0b013e31819faab2. Cardiol Rev. 2009. PMID: 19384087 Review.
• The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.

  Aguilar D, Bozkurt B, Pritchett A, Petersen NJ, Deswal A. Aguilar D, et al. J Am Coll Cardiol. 2007 Jul 3;50(1):32-6. doi: 10.1016/j.jacc.2007.01.096. Epub 2007 Jun 18. J Am Coll Cardiol. 2007. PMID: 17601542
• Pioglitazone-induced heart failure despite normal left ventricular function.

  Shah M, Kolandaivelu A, Fearon WF. Shah M, et al. Am J Med. 2004 Dec 15;117(12):973-4. doi: 10.1016/j.amjmed.2004.10.010. Am J Med. 2004. PMID: 15629744 No abstract available.
• Avandia in perspective.

  Comarow A. Comarow A. US News World Rep. 2007 Oct 1;143(11):71. US News World Rep. 2007. PMID: 17957906 No abstract available.